Marika Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Marika Inc
TickerPVLA
CIK #0001583648
CUSIP697947109
SectorTrade & Services - Services-Business Services, Nec
Address2360 Corporate Circle Suite 400, Henderson, NV 89074
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Pieris Pharmaceuticals Inc 2019-11-20 32.0 M Exemption: 506(b) · Duration: One year or less · Commission: $796,062 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001583648] 10-K
[0001583648] 10-Q
[0001583648] 3
[0001583648] 4
[0001583648] 8-K
[0001583648] D
[0001583648] SC 13D
[0001583648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
First Light Asset Management LLC Palvella Therapeutics Inc [2026-02-17] 0.0
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08] 0.0
Kaupinen WES Palvella Therapeutics Inc [2024-12-20] 0.0
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20] 0.0
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20] 0.0
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07] 0.0
ADAR1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01] 10.5
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12] 6.0
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2023-05-22] 11.8
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2023-01-27] 5.4
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24] 5.1
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2022-01-27] 5.4
Citadel Advisors LLC Pieris Pharmaceuticals Inc [2021-07-06] 4.9
Astrazeneca PLC Pieris Pharmaceuticals Inc [2021-04-08] 5.66
Seagen Inc Pieris Pharmaceuticals Inc [2021-04-02] 6.2
Nussbaum Ran Pieris Pharmaceuticals Inc [2021-02-16] 6.4
BlackRock Inc Pieris Pharmaceuticals Inc [2020-02-07] 6.2
EcoR1 Capital LLC Pieris Pharmaceuticals Inc [2019-11-14] 8.8
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07] 5.1
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2016-06-17] 4.1
Lombard Odier Asset Management USA Corp Pieris Pharmaceuticals Inc [2016-02-16] 7.17
Tekla Capital Management LLC Pieris Pharmaceuticals Inc [2016-02-12] 0.7
Novo Nordisk A S Pieris Pharmaceuticals Inc [2016-01-28] 5.2
Global Life Bioventure IV SARL Pieris Pharmaceuticals Inc [2015-09-11] 6.25
Tompkins Mark N Pieris Pharmaceuticals Inc [2015-07-10] 5.6
OrbiMed Advisors LLC Pieris Pharmaceuticals Inc [2015-07-09] 18.8
Form 3/4/5 Filer 2011 - 2026
Palvella Therapeutics Inc
Pauls Matthew
Goin Kathleen
Korenberg Matthew E
Davis Todd C
Heron Elaine J
Doux John
Kiritsy Christopher P
Wessel Tadd S
Jenkins George M
Kline Ashley Hartmann
Martini Jeffrey S
Kaupinen Wes
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Dellora Investments LP
Geraghty James A
ADAR1 Partners LP
ADAR1 Capital Management LLC
Barbier Ann
Said Maya R
Sherman Matthew L
Kiener Peter A
Richman Michael
Bures Thomas
Kaufmann Hitto
Mousa Ahmed
Yoder Stephen S
Olwill Shane
Demuth Tim
Aquilo Capital Management LLC
Bizzari Jean-Pierre
Reine Allan
Matis Louis
Prelack Steven
OrbiMed Advisors LLC
OrbiMed Capital GP III LLC
Adams Julian
Isaly Samuel D
Khuong Chau Quang
Thibault Lance E
Knopf Claude
Deptula-Hicks Darlene M
Takke Christina
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,154 $0.00
Goin Kathleen
Common Stock
2026-03-18 Option exercise 2,154 $7.14 15,380
Goin Kathleen
Common Stock
2026-03-18 Option exercise 2,148 $9.08 19,504
Goin Kathleen
Common Stock
2026-03-18 Sell 1,730 $118.37 204,780
Goin Kathleen
Common Stock
2026-03-18 Sell 304 $119.08 36,200
Goin Kathleen
Common Stock
2026-03-18 Sell 2,268 $117.56 266,626
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,148 $0.00
Jenkins George M
Common Stock
2026-02-27 Buy 4,000 $125.00 500,000
Heron Elaine J
Common Stock
2026-02-27 Buy 2,400 $125.00 300,000
Goin Kathleen
Common Stock
2026-02-18 Option exercise 2,154 $7.14 15,380
Goin Kathleen
Common Stock
2026-02-18 Sell 1,276 $79.97 102,042
Goin Kathleen
Common Stock
2026-02-18 Sell 3,026 $79.16 239,538
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,148 $0.00
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,154 $0.00
Goin Kathleen
Common Stock
2026-02-18 Option exercise 2,148 $9.08 19,504
Korenberg Matthew E
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 44,123 $0.00
Martini Jeffrey S
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 64,318 $0.00
Kline Ashley Hartmann
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 38,517 $0.00
Kaupinen Wes
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 124,603 $0.00
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 48,956 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 182 13,407,703
2025-12-31 145 10,050,735
2025-09-30 100 8,550,626
2025-06-30 66 5,919,649
2025-03-31 42 5,123,399
2024-12-31 34 4,033,115
Form 13F Holdings
Firm Period DFND Voting Shares
Aspiriant LLC [2026-06-30] SOLE 0 5,852
Spire Wealth Management [2026-06-30] SOLE 0 1,000
Eastern Bank [2026-06-30] DFND 52 52
Gamma Investing LLC [2026-06-30] DFND 37 37
Farther Finance Advisors LLC [2026-06-30] SOLE 0 13
Corecap Advisors LLC [2026-06-30] SOLE 0 11
Fortitude Family Office LLC [2026-06-30] SOLE 5 5
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com